Nonetheless, bilateral salpingo-oophorectomy by age 35 for BRCA1 mutation carriers and 45 for BRCA2 mutation is strongly recommended to prevent ovarian cancer, and has also been shown to impact on survival [7,63]. This evidence concerns the gene BRCA1 and ovarian cancer.